Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
about
Redox control of microglial function: molecular mechanisms and functional significance7,8-dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in rats.A comparative profile of methanol extracts of Allium cepa and Allium sativum in diabetic neuropathy in miceEvaluation of Antioxidant and Cerebroprotective Effect of Medicago sativa Linn. against Ischemia and Reperfusion InsultOne-step isolation of sappanol and brazilin from Caesalpinia sappan and their effects on oxidative stress-induced retinal death.Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism.Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.Neuroprotective activity of Stereospermum suaveolens against global cerebral ischemia rat model.Effects of surgical menopause and estrogen replacement therapy on serum paraoxonase activity and plasma malondialdehyde concentration.Protective effects of the nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate in bladder ischemia-reperfusion injury in rats.Aging and oxidative stress in progressive supranuclear palsy.Simple and sensitive determination of malondialdehyde in human urine and saliva using UHPLC-MS/MS after derivatization with 3,4-diaminobenzophenone.Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
P2860
Q27000279-1EA683BF-1B73-4B8D-A06E-BDCCB82042CAQ34371932-E0ED0399-DCFD-4327-A108-5E58E67230CDQ35036226-4BB4B62F-FF8C-46F5-BA8B-B72C58AB16B3Q35108917-1AFBE7F0-1075-4343-BA44-3A32103BA89DQ35271753-A700672E-6A8B-45F6-ADAB-B853BD49EC2BQ35828024-7A4004DB-04EB-49AB-9165-D57830956841Q36662870-0BB58CFA-0CCA-4A50-AA86-534E4809D90AQ43107252-6DB096E1-F7C9-4A6E-9F3C-4CE7D9F4E1FEQ43996954-86B88796-E3C5-462F-9CF7-AC73D7CAFC48Q45183296-8783B8FF-5B78-44C9-8453-B1ECC92FC5DFQ46033859-57EDF808-EC57-41B4-B1AD-2A59ACA92EB7Q46899416-6A02EFF8-F55F-4FAA-98D7-48A98CDC23B8Q47917201-9BD3B7AA-89DB-4B43-ABC7-F6AF6EE5A476Q48383092-7B38BD12-1853-4CD2-BA1A-DA81CCF314AE
P2860
Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Can malondialdehyde be used as ...... in neurodegenerative disease?
@ast
Can malondialdehyde be used as ...... in neurodegenerative disease?
@en
Can malondialdehyde be used as ...... in neurodegenerative disease?
@nl
type
label
Can malondialdehyde be used as ...... in neurodegenerative disease?
@ast
Can malondialdehyde be used as ...... in neurodegenerative disease?
@en
Can malondialdehyde be used as ...... in neurodegenerative disease?
@nl
prefLabel
Can malondialdehyde be used as ...... in neurodegenerative disease?
@ast
Can malondialdehyde be used as ...... in neurodegenerative disease?
@en
Can malondialdehyde be used as ...... in neurodegenerative disease?
@nl
P2093
P356
P1433
P1476
Can malondialdehyde be used as ...... in neurodegenerative disease?
@en
P2093
Alain Favier
Catherine Garrel
Claude Desnuelle
Michel Dib
Valérie Robin
P2888
P304
P356
10.1007/S004150200025
P577
2002-04-01T00:00:00Z
P6179
1023600493